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ABSTRACT The UvrC protein is one of three subunits of
the Escherichia coli repair enzyme (A)BC excinuclease. This
subunit is thought to have at least one of the active sites for
nucleophilic attack on the phosphodiester bonds of damaged
DNA. To localize the active site, mutant UvrC proteins were
constructed by linker-scanning and deletion mutagenesis. In
vivo studies revealed that the C-terminal 314 amino acids of the
610-amino acid UvrC protein were sufficient to confer UV
resistance to cells lacking the uvrC gene. The portion of the
uvrC gene encoding the C-terminal half of the protein was fused
to the 3' end of the E. coli malE gene (which encodes maltose
binding protein), and the fusion protein MBP-C314C was
purified and characterized. The fusion protein, in combination
with UvrA and UvrB subunits, reconstituted the excinuclease
activity that incised the eighth phosphodiester bond 5' and the
fourth phosphodiester bond 3' to a psoralen-thymine adduct.
These results suggest that the C-terminal 314 amino acids of
UvrC constitute a functional domain capable of interacting
with the UvrB-damaged DNA complex and of inducing the two
phosphodiester bond incisions characteristic of (A)BC excinu-
clease.
(A)BC excinuclease is the collective activity of UvrA, UvrB,
and UvrC proteins of Escherichia coli (1, 2). The enzyme
initiates nucleotide excision repair of DNA damage ranging
from covalently modified bases (2) to noncovalent drug-
nucleotide complexes (3, 4) to abasic sites generated by
oxidative metabolism or ionizing radiation (5, 6). This type of
enzymatic activity appears to be widespread in both pro- and
eukaryotes (1, 7). Therefore, understanding the details of
nucleotide excision repair in E. coli is likely to contribute to
studies of DNA repair in other biological systems as well.
The reaction mechanism of (A)BC excinuclease has been
investigated in some detail (8, 9). These studies have revealed
a unique mechanism for high-affinity binding to damaged
DNA and specific removal of modified nucleotides. UvrA,
which has a moderate affinity to damaged DNA compared to
unmodified DNA, makes a (UvrA)2(UvrB)1 complex and this
complex delivers UvrB to the damaged site; a very stable
UvrB-DNA complex is formed and UvrA dissociates from
the site. UvrC, which has no affinity for free UvrB, binds to
the UvrB-DNA complex with high affinity and specificity
and induces the cleavage of the eighth phosphodiester bond
5' and the fourth or fifth phosphodiester bond 3' to the
damaged nucleotide. Since both UvrB and UvrC are present
in the incision complex, it is unclear at present which of the
two subunits is responsible for the dual nucleophilic attack on
the phosphodiester backbone. It has been reported that UvrC
has a weak nonspecific nuclease activity (10), which would
suggest that at least one of the specific incisions is made by
UvrC.
The uvrC gene of E. coli encodes a protein of 610 amino
acids and a molecular weight of 68,510 (7, 11). To define the
role of UvrC in excision repair more specifically and to
identify the active site(s) within the protein, we mutagenized
the gene by linker-scanning mutagenesis. The results ob-
tained by this method led us to make plasmid constructs that
expressed only parts of the gene from the N or C termini. We
found that a plasmid expressing the 314 C-terminal amino
acids of the protein complemented uvrC- mutations in vivo.
A fusion protein (MBP-C314C) was constructed in which the
sequence for the maltose binding protein (MBP) was fused to
the sequence for the C-terminal 314 amino acids ofUvrC. The
fusion protein was purified and was found to produce the two
incisions typical of (A)BC excinuclease when mixed with
UvrA and UvrB proteins. We conclude that the C-terminal
half ofUvrC carries all the structural requirements necessary
for (A)BC excinuclease activity.
MATERIALS AND METHODS
Materials. The E. coli K-12 DR1984 (uvrC34 recAl) was
used as a host for initial testing of the complementing
activities of various plasmids carrying mutant uvrC genes
(11). The mutant genes that were studied in more detail were
also tested in E. coli N3024 (uvrC 279: :TnlO), a strain with a
TnJO insertion in the 3' half ofuvrC (12). Finally, by "curing"
N3024 of the TnJO insertion, we obtained UNC3024(AuvrC)
in which at least 60o of the 5' terminal half of the uvrC gene
has been deleted, as determined by Southern blot analysis
using the 1.2-kilobase-pair Bgl I-Nco I fragment of uvrC as
the probe (11). The S1 nuclease, T4 DNA polymerase, and
restriction enzymes were purchased from Bethesda Research
Laboratories. E. coli endonuclease IV (13) was kindly pro-
vided by B. Demple (Harvard University). UvrA, UvrB, and
UvrC proteins were purified according to Thomas et al. (14).
The pMAL-c plasmid used for gene fusions was obtained
from New England Biolabs.
Construction of Linker-Scanning and Deletion Mutants.
Linker-scanning mutants of uvrC (Fig. 1) were generated in
the UvrC-overproducing plasmid pDR3274 (11) as described
(15). Briefly, an average of one apurinic site per plasmid was
introduced by heating pDR3274 at 65°C at pH 5.2 for 30 min
(5). The plasmid was then treated with endonuclease IV and
S1 nuclease to induce a double-strand break. The linearized
DNA was then ligated to the 8-base-pair (bp) Sst I linker
CGAGCTCG. The plasmids were transformed into DR1984
and tested for phenotypic complementation by UV survival
and the sites of linker insertion were mapped by restriction
analysis. The exact locations of the inserts in plasmids of
interest were determined by double-stranded DNA sequenc-
ing.
Plasmids expressing the N-terminal fragments of UvrC
(1-182 and 1-404 amino acids with internal deletions of
Abbreviation: MBP, maltose binding protein.
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FIG. 2. UvrC C- and N-terminal deletions. The
C404NA1 4.1 x 1 6 wild-type protein is 610 amino acids long. The
deletion mutants are indicated by the number and
relative locations of the amino acids they are pre-
C404NA2 1.7 x 1 6 dicted to contain. The constructs that encode N-ter-
minal peptides C4O4NA&1 and C40NA2 carry the
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nal amino acids of UvrC protein. The survivals of
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(5 ergs/mm2)are listed. Survivals within an order of
2.0 x 10 magnitude of one another are not considered to be
significantly different. Identical results were ob-
tained in the AuvrC null background (data not
uvrC strain 3.9 x 10 shown).
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plasmids expressing the C-terminal fragments of UvrC from
the tac promoter on the expression vector.
UV Survival. Cells harboring the appropriate plasmids
were grown in Luria broth containing the appropriate anti-
biotics. The cells were diluted in phosphate-buffered saline,
plated on Luria broth agar plates, and irradiated at 254 nm
with a General Electric germicidal lamp at a fluence rate of
5 ,uW/cm2. After irradiation the plates were incubated at 370C
for 24 hr before counting colonies to measure survival
relative to unirradiated cells.
Construction of maLE-uvrC Fusion. Plasmid pMAL-C314C
carrying the coding region of the C-terminal 314 amino acids
of the UvrC protein fused to the gene for the MBP was
constructed as follows. The linker-scanning mutant plasmid
pUvrCA(546-885), which contains an Sst I insert at the 546-
to 885-bp deletion site, was digested with Sst I, and the site
was "blunted" with T4 DNA polymerase and ligated with the
8-bp Xba I linker GTCTAGAC. The DNA was then digested
with Xba I and Pst I and the fragment carrying the 942-bp
3'-terminal part of the uvrC gene was purified. The purified
fragment was then inserted into pMAL-c plasmid (New
England Biolabs) that had been digested with Xba I and Pst
I. The resulting construct pMAL-C314C contains the 942-bp
3' terminal base pairs of uvrC linked to the 3' terminus of the
malE gene by a linker region that encodes a factor Xa
cleavage site.
PIulfcaton of the MBP-C314C Fusion Protein. E. coli
DR1984/pMAL-C314C cells were grown and induced with
isopropyl f3-D-thiogalactopyranoside according to the manu-
facturer's manual. The fusion protein that constituted =40o
of total cellular proteins was purified by chromatography on
single-stranded DNA-cellulose and phosphocellulose as de-
scribed for the Bacillus subtilis UvrC protein (7). The fraction
from the phosphocellulose column was subjected to affinity
chromatography on an amylose-cellulose column to remove
minor contaminants that remain after the first two purifica-
tion steps.
Repair Assay. This assay measures the excision ofa 12-mer
containing a nucleotide adduct by (A)BC excinuclease. The
substrate used was a 137-mer duplex with a centrally located
furan-side thymine-psoralen monoadduct that had 32P-label
at the sixth phosphate 5' to the adduct; thus incisions by
(A)BC excinuclease result in the release of a radiolabeled
12-mer. The 137-mer substrate was constructed as described
(16) using the psoralen-adduct-containing dodecanucleotide
kindly provided by J. E. Hearst (University of California,
Berkeley). The (A)BC excinuclease reactions were per-
formed in a 25-,ul reaction mixture containing 50 mM
Tris HCl (pH 7.5), 100 mM KCI, 10 mM MgCl2, 2 mM ATP,
5 mM dithiothreitol, bovine serum albumin (50 ,ug/ml), 5 nM
UvrA, 65 nM UvrB, and -2000 cpm of 32P-labeled 137-mer.
The reaction mixtures were incubated at 370C for 30 mn, then
the indicated amounts of UvrC or MBP-C314C were added,
incubation at 370C was continued for another 30 min, and the
reactions were stopped by adding 1 Al of oyster glycogen (10
mg/ml) and 60 ,ul of ice-cold ethanol. The precipitated DNA
was collected by centrifugation, dried, resuspended in a
formamide/dye mixture (16), and analyzed on a 12% se-
quencing gel. The autoradiograms were scanned with a
densitometer (Zeineh Softlaser densitometer model SLR
2D/D)-to quantify excision.
RESULTS
Linker-Scning Mutants of UvrC. In linker-scanning mu-
tagenesis, short "linker" oligonucleotides are inserted ran-
doimly into a gene to identify the important regions for the
structural-functional integrity of a protein. Using this meth-
odology, we isolated 200 mutants in pDR3274(uvrC). Many of
these were characterized by restriction mapping and 11
mutants, which were of particular interest, were further
characterized by double-stranded DNA sequencing. All our
mutants had extensive deletions from 134 bp A(1453-1465) to
340 bp A(546-885), presumably as a result ofoverdigestion by
S1 nuclease during linearization of nicked DNA. Neverthe-
less, we were able to draw some conclusions regarding the
structural organization of UvrC from the in vivo properties of
these mutants.
Fig. 1 shows a schematic map of linker-scanning deletion
mutants investigated and the phenotypic effect of these
mutations. Sequence analysis shows that constructs A(423-
832), A(487-515), and A(532-623) are in-frame fusions after
the deletion-insertion reactions used to generate the mutants.
With this fact in mind then and by assuming equal abundance
of mutant proteins, the phenotypes of the mutants shown in
Fig. 1 give a conflicting picture. Thus, loss of function in
A(487-515) would indicate that the 10 amino acids deleted in
this mutant are essential for function and, therefore, the
N-terminal part of UvrC is vital for its complementing
activity. Yet the mutant A(423-832) results in deletion of 137
amino acids including those deleted in A(487-515) but the
resulting protein complements the uvrC- mutation almost to
the wild-type level. In contrast, construct A(532-623), which
is missing only a subset of the amino acids deleted in
A(423-832), is also deficient in complementation. The out-
of-frame deletion-insertion mutants A(546-855), A(636-707),
and A(952-1014) complement the UvrC- phenotype, which
implies that the region of uvrC beyond bp 635 (212 amino
acids) is not required for activity. However, the last four
deletion-insertion constructs that express more than the first
317 N-terminal amino acids of UvrC are defective in com-
plementation, indicating that the C-terminal half is required
for function.
Deletion Mutants of UvrC. To reconcile the seemingly
contradictory data emerging from the deletion-insertion mu-
tants, we constructed plasmids that expressed regions either
from the N-terminal or C-terminal halves of UvrC protein.
Fig. 2 is a schematic representation of the deletion mutants
tested. C182N and C404NA1 were derived from the comple-
menting A(546-885) and C404NA2 was derived from the
complementing A(636-707) deletion-insertion mutants.
These constructs, which express only N-terminal portions of
UvrC, failed to complement uvrC7 mutations. In contrast,
constructs C375C and C314C complemented the UvrC(
phenotype either fully or partially. The last three constructs
shown in Fig. 2, which express the C-terminal 272, 223, or 207
amino acids, failed to complement the UvrC- phenotype.
As these results were somewhat contradictory to those
obtained with the deletion-insertion mutants, we considered
the possibility of an "aa-complementation" type of an inter-
action between the mutant chromosomal protein (the nature
of the mutation in uvrC34 is not known) and the truncated
proteins expressed from the plasmid constructs. Therefore,
we tested the constructs in UNC3024(AuvrC) in which the
region of uvrC spanning at least Bgi I-Nco I fragment (Fig.
1) has been deleted; the complementation pattern was the
same (data not shown) as in DR1984 (uvrC34 recAl). There-
fore, we conclude that the C-terminal 314 amino acids of
UvrC protein are sufficient for UvrC activity.
Consdion Propers of MBP-C314C. Although the
deletion mutants provided strong evidence for functional
complementation by the C-terminal half of UvrC, the trun-
cated proteins were not overproduced even when joined to
the artificial tac promoter and, therefore, were not amenable
to biochemical analysis. Thus we could not ascertain from the
in vivo data whether the excinuclease reconstituted with
UvrC-314C incised on both sides ofthe damage as the normal
enzyme does or nicked only 5' to the DNA adduct. It is
known that the 5' incision to pyrimidine dimers results in the
eventual removal of the photodimers by the 5' -) 3' exonu-
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clease activity of DNA polymerase I (1). Lack of overpro-
duction of truncated proteins is usually due to decreased
stability of the mRNA or of the truncated peptide. The
stability is often increased by fusing to another gene. It has
been shown that the MBP ofE. coli stabilizes a proteinjoined
to its C terminus (17). Furthermore, the high affinity ofMBP
to amylose offers a convenient method for purifying the
fusion proteins by affinity chromatography.
We joined the 3' terminal 942 bp of uvrC to the polylinker
region (which encodes factor Xa recognition site) at the 3'
terminus of malE in pMAL-c to obtain a malE-uvrC fusion
under the control of a tac promoter (17). The resulting
plasmid pMAL-C314C complemented the UV-sensitive phe-
notype ofDR1984 (Fig. 3) as well as that of the uvrC deletion
mutant UNC3024 whereas a plasmid expressing the N-ter-
minal polypeptide ofMBP had no effect on survival (data not
shown). Thus, the fusion of the MBP to the C-terminal 314
amino acids of UvrC does not interfere with its complement-
ing activity. Note, however, that at all doses tested the
complementation was incomplete. Since even under nonin-
ducing conditions the fusion protein is overproduced com-
pared to the 10 molecules of wild-type UvrC present in the
control cells (1), it is clear that the fusion protein has reduced
activity compared to wild type. However, no quantitative
statement can be made from this data regarding the activity
of the fusion protein.
Purification of the MBP-C314C Fusion Protein. The fusion
protein was purified from a 500-ml culture of isopropyl
13-D-thiogalactopyranoside-induced DR1984 FlaciQ/pMAL-
C314C. The cell-free extract, in which 40%o of soluble protein
was MBP-C314C, was loaded directly onto a single-stranded
DNA-cellulose column. The fusion protein bound to this
column with nearly the same affinity as wild-type UvrC and
was further purified by successive chromatography on phos-
phocellulose and amylose resins. The final product was a
76-kDa protein at >99%o purity, as determined by SDS/
PAGE (Fig. 4). The fact that the fusion protein bound to
single-stranded DNA and phosphoceilulose resins with the
same affinity as wild-type UvrC would indicate that the
overall physical properties of MBP-C314C are similar to
UvrC and in particular that the DNA binding site is located
within the C-terminal 314 amino acids of UvrC (MBP has no
affinity to DNA). Digestion ofthe purified fusion protein with
factor Xa under optimal conditions yielded the C-terminal
domain of UvrC with =50%o yield (data not shown).
Reconstitution of (A)BC Excinuclease with MBP-C314C. A
plasmid-nicking assay that measures the conversion of su-
perhelical DNA to open circles (5), with wild-type UvrA and
UvrB proteins and MBP-C314C gave an unexpected result.
12
UvrC.- - -'MBP-C314C
FIG. 4. Purified MBP-C314C
fusion protein. Lanes: 1, UvrC
protein (2 lg); 2, MBP-C314C (6
,ug). UvrC is 69 kDa; the predicted
molecular mass of the fusion pro-
tein is 76 kDa. This is a1o poly-
acrylamide gel containing SDS
stained with Coomassie blue.
In contrast to the near-wild-type level of complementation in
vivo, the nicking activity with enzyme reconstituted with the
fusion protein was barely detectable above background nick-
ing (data not shown). We reasoned that the poor comple-
mentation in vitro might be due to the MBP part of the fusion
that might be cleaved off in vivo by nonspecific proteases.
Therefore, we conducted a plasmid-nicking assay with an
enzyme reconstituted with a factor Xa-cleaved fusion pro-
tein. We saw no improvement over what could be achieved
with the fusion protein alone and concluded that such a
drastic reduction in activity is the result of deleting the
N-terminal 295 amino acids of UvrC.
The low level of nicking activity observed with the enzyme
reconstituted with the fusion protein precluded any firm
conclusion regarding the specificity of the nicking. We de-
cided to ascertain the specificity by conducting an "excision
assay" (7). (A)BC excinuclease incises damaged DNA in a
unique manner: it hydrolyzes the eighth phosphodiester bond
5' and the fourth or fifth phosphodiester bond 3' to the
modified nucleotide resulting in the release of a 12- or a
13-mer (22). Therefore, if the low-level nuclease activity
observed with the enzyme reconstituted with MBP-C314C is
true (A)BC excinuclease activity, we would expect to see
such an excision fragment with this system.
The experiment was conducted with an internally labeled
137-bp duplex containing a psoralen monoadduct near the
internal label. Fig. 5 shows the incision products of (A)BC
excinuclease reconstituted with 5 nM UvrA, 65 nM UvrB,
and either 40 nM UvrC or 320 nM MBP-C314C fusion
protein. A 12-mer carrying the psoralen adduct was excised
by both systems. However, the level of excision, determined
by densitometric scanning of the excised band, was 10 times
more efficient in the reaction mixture containing wild-type
protein and, considering that we used 8 times less wild-type
UvrC than fusion protein, we calculate the fusion protein to
have -1.25% the activity of wild-type UvrC. Although this
activity is sufficient to achieve near-normal in vivo comple-
mentation when the protein is overproduced, it is too low to
be detected by the less-specific plasmid-nicking assay. As in
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FIG. 3. UV survival of DR1984 (recAl uvrC34) containing vari-
ous plasmids. m, DR1984 with no plasmid; n, DR1984/pDR3274
(uvrC'); A, DR1984/pMAL-C314C (tac-malE-uvrC). Cultures were
grown to stationary phase in Luria broth, and dilutions were plated
on Luria agar plates and irradiated (254 nm) at a fluence rate of 5
ILW/cm2. S/So, relative survival.
v - 12-mer
FIG. 5. Excision of psora-
len monoadduct by (A)BC ex-
cinuclease reconstituted with
the MBP-C314C fusion pro-
tein. A 137-mer duplex con-
taining 32P-label at the sixth
phosphodiester bond 5' to the
adduct was incubated with the
indicated proteins (+, protein
present; -, protein absent) at
370C for 30 min and the prod-
ucts were analyzed on a 12%
polyacrylamide sequencing
gel. The protein concentra-
tions were 5 nM UvrA, 65 nM
UvrB, and either 40 nM UvrC
or 320 nM MBP-C314C fusion
product. The excised 12-mer
carrying the psoralen adduct
comigrates with an unmodified
13-mer size marker.
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did not improve the efficiency of excision by the enzyme
reconstituted with the C terminus of UvrC (data not shown).
Thus, it appears that low efficiency of excision is an intrinsic
property of this system. This low efficiency of incision,
notwithstanding our results, enables us to conclude that the
C-terminal 314 amino acids of UvrC are sufficient to produce
the unique incision pattern of (A)BC excinuclease.
DISCUSSION
UvrC binds specifically to UvrB-damaged DNA complexes
and induces the dual incision characteristic of (A)BC exci-
nuclease. There are three forfal possibilities as to how the
incisions are made. (i) UvrB may simply target UvrC to the
damage site and UvrC makes both incisions. (i) UvrC may
bind to the UvrB-DNA complex and induce a conformational
change in one or both components of this complex to position
the two target phosphodiester bonds in proximity of the
nucleophiles in UvrB. (iii) Finally, UvrC may bind to the
UvrB-DNA complex, make one of the incisions, and induce
a conformational change in the complex to enable UvrB to
make the second incision, not -necessarily in this temporal
order. Some indirect evidence such as the weak nonspecific
nuclease activity detected in UvrC preparations (10), the
preferential inhibition of 5' incision by either high pH or
"aged" UvrC samples (1, 2), and the absolute lack ofincision
by DNA-bound UvrB alone lead us to favor the third alter-
native-that is, that one of the nucleophilic sites is on UvrB
and the other is on UvrC. Based on this premise, we have
proceeded herein to localize the active site of UvrC and have
narrowed down the region to the C-terminal 314 amino acids
of the 610-amino acid protein.
The approach we have used, generation of out-of-frame
fusions and of internal and N- and C-terminal deletions and
testing of these constructs by in vivo complementation is
subject to potential pitfalls (18): recombination with the
chromosomal gene, restoration of lost function by noncova-
lent interaction of the chromosome-encoded and plasmid-
encoded peptides, and the loss of activity in a fragment
possessing the active site by "'tail" amino acids that may
interfere with proper folding or substrate binding. Finally,
translational frameshift and translational reinitiation and mis-
reading may generate proteins not predicted from DNA
sequence at low frequency (18, 19). When expressed from a
strong promoter such as tac, the levels of such proteins may
be sufficiently high to achieve full complementation. We have
eliminated the two most serious sources of error, recombi-
nation and interpeptide complementation, by using strains
with a RecA- phenotype or a strain deleted in about two-
thirds of the 5' region of uvrC gene. Therefore, we feel that
our main conclusion that the C-terminal 314 amino acids of
UvrC carry the active site of this protein is justified.
However, the results obtained with the deletion-insertion
mutants further underscores the "hazards in the application
of molecular biology to structure-function relationship" am-
ply documented by Schimmel (18). Without the knowledge
gathered from the N- and C-terminal deletion constructs
shown in Fig. 2, it would have been impossible to propose
structure-function model consistent with the phenotypes of
all mutants shown in Fig. 1. Having independently estab-
lished that the C-terminal 314 amino acids are sufficient for
activity, we can explain the phenotypes of all out-of-frame
mutants shown in Fig. 1. There wre in-frame ATG codons at
positions 930 and 1185 in uvrC and the constructs with
complementing activity are more likely to express proteins
from these restart sites. With this assumption, then, the
complementing activity observed with A(1453-1465) out-of-
frame fusion would lead one to conclude that the active site
is located between amino acids 395 (position 1185) and 484
even though the possibility of translational fiameshift in
A(1453-1465) cannot be discounted.
The in-frame deletion fusions reveal another interesting
aspect of this type of analysis. Thus, construct A(423-832),
which encodes a UvrC protein with an internal deletion of 137
amino acids, complements uvrC- mutations whereas the two
other in-frame constructs that are missing subsets ofeither 10
or 37 amino acids of the 137 amino acids deleted in A(423-
832) do not complement. This is perhaps due to the damp-
ening effect of the N-terminal "tails" on the function of
mutant proteins as has been observed with glycine tRNA
synthetase (20): a deletion of N-terminal 178 amino acids of
the (3 chain results in an inactive synthetase; however,
deletion of the N-terminal 306 amino acids yields a fully
active ( subunit, apparently because ofremoval of "activity-
masking residues."
The data from in- and out-of-frame fusions, N- and C-ter-
minal deletions, and finally the MBP fusion protein are
consistent with the C-terminal 314 amino acids containing the
active site of UvrC. It might be asked then what roles the N-
and C-terminal halves ofUvrC play in the incision reactions.
We offer the following model: the C-terminal 314 amino acids
carry the nucleophile responsible for one of the incisions,
perhaps the 5' incision as (A)BC excinuclease reconstituted
with oxidized UvrC is defective in 5' incision (unpublished
observation). The function ofthe N-terminal half is mainly to
make specific protein-protein contacts with UvrB and thus
help form the UvrB-UvrC heterodimer, which makes the
dual incisions. By deleting the N-terminal half of UvrC, we
have created a protein with M100 times less affinity for the
UvrB-DNA complex resulting in a 100 times diminished
excinuclease activity.
It is interesting that B. subtilis UvrC (21), which can
substitute forE. coli UvrC in vivo and in vitro (7), has a higher
level ofhomology to E. coli UvrC in the N-terminal half(44%)
compared to the C-terminal half(301%). This is consistent with
our model that the N-terminal half is involved mainly in
protein-protein interaction. Such interactions impose strin-
gent selection on types of substitutions that can be made
without significantly altering function.
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